Operator Good day, and welcome to the Bionano fourth quarter 2024 earnings conference call. Today's conference is being ...

Analysts estimate that Bionano Genomics will report an earnings per share (EPS) of $-8.40. The announcement from Bionano ...

Scotiabank raised the firm’s price target on Bionano Genomics (BNGO) to $4 from $1 and keeps a Sector Perform rating on the shares. Despite the ...

Shares of NASDAQ:BNGO opened at $3.36 on Wednesday. Bionano Genomics has a 52-week low of $2.68 and a 52-week high of $72.60. The stock has a market cap of $9.18 million, a P/E ratio of -0.02 and ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.

BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-60. The effective time of the reverse stock split will be ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bionano Genomics wasn’t one of them. The 10 stocks that made ...